March 6, 2026News CoverageCalidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public OfferingCalidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering Short Term Tranche Warrants Potentially…
October 9, 2023News CoverageAnalyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
October 9, 2023News CoverageCalidi Biotherapeutics: A Promising Player in the Cancer Treatment Market
April 27, 2020News CoverageCalidi’s Contribution To The Treatment Of COVID-19In A Short Time, The Novel Coronavirus Disease (COVID-19) Has Destructively Impacted Both The People…
